Remotely monitored inactivity due to COVID-19 lockdowns

References

1. ↵
   1. Kawabata M,
   2. Fantoni C,
   3. Regoli F,
   4. Raffa S,
   5. Pastori F,
   6. Fratini S,
   7. et al.

   (2007) Activity monitoring in heart failure patients with cardiac resynchronization therapy. Circ J 71:1885–1892.

   OpenUrlCrossRefPubMedWeb of ScienceGoogle Scholar
2. ↵
   1. Kaszala K,
   2. Ellenbogen KA

   (2010) Device Sensing. Circulation 122:1328–1340.

   OpenUrlFREE Full TextGoogle Scholar
3. ↵
   1. Rosman L,
   2. Lampert R,
   3. Sears SF,
   4. Burg MM

   (2018) Measuring Physical Activity With Implanted Cardiac Devices:A Systematic Review. Journal of the American Heart Association 7:e008663.

   OpenUrlAbstract/FREE Full TextGoogle Scholar
4. ↵
   1. World Health Organization. Physical activity

   , Update 2018 February 23, Available from: https://www.who.int/news-room/fact-sheets/detail/physical-activity. Accessed 2020 May 15.

   Google Scholar
5. ↵
   1. Heart Rhythm Society. HRS COVID-19 Task Force. [Update 2020 April 15]

   , Available from: https://www.hrsonline.org/COVID19-Challenges-Solutions/hrscovid-19-task-force-update-april-15-2020. Accessed 2020 May 17.

   Google Scholar
6. ↵
   1. Shoemaker M,
   2. Cartwright K,
   3. Hanson K,
   4. Serba D,
   5. Dickinson M,
   6. Kowalk A

   (2017) Concurrent Validity of Daily Activity Data from Medtronic ICD/CRT Devices and the Actigraph GT3X Triaxial Accelerometer:A Pilot Study. Cardiopulmonary Physical Therapy Journal 28:3–11.

   OpenUrlGoogle Scholar
7. ↵
   1. Wilkoff BL,
   2. Auricchio A,
   3. Brugada J,
   4. Cowie M,
   5. Ellenbogen KA,
   6. Gillis AM,
   7. et al.

   (2008) HRS/EHRA Expert Consensus on the Monitoring of Cardiovascular Implantable Electronic Devices (CIEDs):description of techniques, indications, personnel, frequency and ethical considerations:developed in partnership with the Heart Rhythm Society (HRS) and the European Heart Rhythm Association (EHRA);and in collaboration with the American College of Cardiology (ACC), the American Heart Association (AHA), the European Society of Cardiology (ESC), the Heart Failure Association of ESC (HFA), and the Heart Failure Society of America (HFSA). Endorsed by the Heart Rhythm Society, the European Heart Rhythm Association (a registered branch of the ESC), the American College of Cardiology, the American Heart Association. Europace 10:707–725.

   OpenUrlGoogle Scholar
8. 1. Varma N,
   2. Epstein AE,
   3. Irimpen A,
   4. Schweikert R,
   5. Love C

   (2010) Efficacy and safety of automatic remote monitoring for implantable cardioverter-defibrillator follow-up:the Lumos-T Safely Reduces Routine Office Device Follow-up (TRUST) trial. Circulation 122:325–332.

   OpenUrlAbstract/FREE Full TextGoogle Scholar
9. ↵
   1. Crossley GH,
   2. Boyle A,
   3. Vitense H,
   4. Chang Y,
   5. Mead RH

   (2011) The CONNECT (Clinical Evaluation of Remote Notification to Reduce Time to Clinical Decision) trial:the value of wireless remote monitoring with automatic clinician alerts. J Am Coll Cardiol 57:1181–1189.

   OpenUrlFREE Full TextGoogle Scholar
10. ↵
    1. Schoenfeld MH,
    2. Compton SJ,
    3. Mead RH,
    4. Weiss DN,
    5. Sherfesee L,
    6. Englund J,
    7. et al.

    (2004) Remote monitoring of implantable cardioverter defibrillators:a prospective analysis. Pacing Clin Electrophysiol 27(6 Pt 1):757–763.

    OpenUrlCrossRefPubMedGoogle Scholar
11. 1. Theuns DA,
    2. Rivero-Ayerza M,
    3. Knops P,
    4. Res JC,
    5. Jordaens L

    (2009) Analysis of 57,148 transmissions by remote monitoring of implantable cardioverter defibrillators. Pacing Clin Electrophysiol 32(Suppl 1):S63–S65.

    OpenUrlPubMedGoogle Scholar
12. ↵
    1. Lazarus A

    (2007) Remote, wireless, ambulatory monitoring of implantable pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy systems:analysis of a worldwide database. Pacing Clin Electrophysiol 30(Suppl 1):S2–S12.

    OpenUrlPubMedGoogle Scholar
13. ↵
    1. Pressler A,
    2. Danner M,
    3. Esefeld K,
    4. Haller B,
    5. Scherr J,
    6. Schömig A,
    7. et al.

    (2013) Validity of cardiac implantable electronic devices in assessing daily physical activity. Int J Cardiol 168:1127–1130.

    OpenUrlCrossRefPubMedGoogle Scholar
14. ↵
    1. Lancet T

    (2020) COVID-19:too little, too late? The Lancet 395:10226.

    OpenUrlGoogle Scholar
15. ↵
    1. Lippi G,
    2. Sanchis-Gomar F

    (2020) An Estimation of the Worldwide Epidemiologic Burden of Physical Inactivity-Related Ischemic Heart Disease. Cardiovasc Drugs Ther 34:133–137.

    OpenUrlGoogle Scholar
16. ↵
    1. Dickinson MG,
    2. Dam AV,
    3. Schuman E,
    4. McLeod J,
    5. Cartwright K,
    6. Schuurman C,
    7. et al.

    (2019) Quantification of seasonal variation in daily physical activity in individuals with heart failure and implantable cardioverter defibrillator/cardiac resynchronisation therapy devices. Heart International 13:2.

    OpenUrlGoogle Scholar
17. ↵
    1. Yezli S,
    2. Khan A

    (2020) COVID-19 social distancing in the Kingdom of Saudi Arabia:Bold measures in the face of political, economic, social and religious challenges. Travel Medicine and Infectious Disease 21:101692.

    OpenUrlGoogle Scholar
18. ↵
    1. Hemphill NM,
    2. Kuan MT,
    3. Harris KC

    (2020) Reduced physical activity during COVID-19 pandemic in children with congenital heart disease. Can J Cardiol 36:1130–1134.

    OpenUrlGoogle Scholar
19. ↵
    1. Small RS,
    2. Wickemeyer W,
    3. Germany R,
    4. Hoppe B,
    5. Andrulli J,
    6. Brady PA,
    7. et al.

    (2009) Changes in intrathoracic impedance are associated with subsequent risk of hospitalizations for acute decompensated heart failure:clinical utility of implanted device monitoring without a patient alert. J Card Fail 15:475–481.

    OpenUrlCrossRefPubMedWeb of ScienceGoogle Scholar
20. ↵
    1. Chelu MG,
    2. Gunderson BD,
    3. Koehler J,
    4. Ziegler PD,
    5. Sears SF

    (2016) Patient activity decreases and mortality increases after the onset of persistent atrial fibrillation in patients with implantable cardioverter-defibrillators. JACC: Clinical Electrophysiology 2:518–523.

    OpenUrlGoogle Scholar
21. ↵
    1. Palmisano P,
    2. Guerra F,
    3. Ammendola E,
    4. Ziacchi M,
    5. Luigi Pisano EC,
    6. Dell'Era G,
    7. et al.

    (2018) Physical activity measured by implanted devices predicts atrial arrhythmias and patient outcome:Results of IMPLANTED (Italian Multicentre Observational Registry on Patients With Implantable Devices Remotely Monitored). J Am Heart Assoc 7(5):e008146.

    OpenUrlAbstract/FREE Full TextGoogle Scholar
22. ↵
    1. Jamé S,
    2. Kutyifa V,
    3. Polonsky B,
    4. McNitt S,
    5. Al-Ahmad A,
    6. Moss AJ,
    7. et al.

    (2017) Predictive value of device-derived activity level for short-term outcomes in MADIT-CRT. Heart Rhythm 14:1081–1086.

    OpenUrlGoogle Scholar
23. ↵
    1. Kramer DB,
    2. Mitchell SL,
    3. Monteiro J,
    4. Jones PW,
    5. Normand SL,
    6. Hayes DL,
    7. et al.

    (2015) Patient activity and survival following Implantable Cardioverter-Defibrillator Implantation:The ALTITUDE Activity Study. J Am Heart Assoc 4(5):e001775.

    OpenUrlAbstract/FREE Full TextGoogle Scholar